MDR1 Gene Expression in Colorectal Cancer
Author Information
Author(s): R. Pirker, J. Wallner, A. Gsur, M. Götzl, S. Zdichbauer, W. Scheithauer, D. Depisch
Primary Institution: University of Vienna Medical School
Hypothesis
Is MDR1 gene expression associated with survival outcomes in colorectal cancer patients?
Conclusion
MDR1 gene expression does not affect the survival durations of colorectal cancer patients.
Supporting Evidence
- MDR1 RNA was detected in 65% of the colorectal carcinomas studied.
- No expression of the MDR2 gene was seen in any of the tumors.
- Survival analysis showed no difference in outcomes based on MDR1 RNA expression.
- Patients with MDR1 positive tumors had similar survival durations to those with negative tumors.
Takeaway
The study looked at a gene called MDR1 in colorectal cancer and found that it doesn't help predict how long patients will live after treatment.
Methodology
MDR1 RNA levels were determined using slot blot analysis on tumor specimens from patients.
Limitations
The study did not find a correlation between MDR1 expression and survival, which may be due to the types of treatments the patients received.
Participant Demographics
58 females and 55 males, median age 60 years.
Want to read the original?
Access the complete publication on the publisher's website